Kallyope
Chan Aye Thu is a Senior Scientist at Kallyope, leading target validation efforts in drug discovery. Previously, at Regeneron Pharmaceuticals, Inc., Chan characterized antibodies for immuno oncology targets. With experience at Columbia University Medical Center, Chan focused on neuronal cell adhesion molecules in neurological diseases. Chan holds a Ph.D. in Cell/Cellular and Molecular Biology from Nanyang Technological University.
This person is not in the org chart
Kallyope
2 followers
Founded and headquartered in New York City, Kallyope is developing an industry-leading platform to harness the gut-brain axis.